Cranial Nerve Diseases  >>  opicinumab (BIIB033)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
opicinumab (BIIB033) / Biogen
NCT02833142: Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes

Completed
1
28
US
BIIB033 (opicinumab)
Biogen
Multiple Sclerosis, Acute Optic Neuritis
11/16
11/16

Download Options